newsfilter
← Earnings
Earnings Releases·

Zoetis — Third Quarter 2026 Earnings Summary

Zoetis reported third-quarter 2026 revenue of $2.4 billion, representing a 1% decrease on both reported and organic operational bases compared to the prior year. Net income for the quarter was $591 million, a decline of 18% from the previous year, while adjusted diluted earnings per share rose 3% to $1.75. The company narrowed its full-year 2026 revenue guidance to a range of $9.220 billion to $9.320 billion and raised its adjusted diluted EPS guidance to between $6.25 and $6.35. Key performance drivers included a 5% increase in U.S. livestock revenue and an 8% rise in international livestock sales, which partially offset an 8% drop in U.S. companion animal revenue.

Company
ZOETIS INC
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic